BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8814476)

  • 1. Haemodynamic study as guideline for the use of beta blockers in acute theophylline poisoning.
    Kempf J; Rusterholtz T; Ber C; Gayol S; Jaeger A
    Intensive Care Med; 1996 Jun; 22(6):585-7. PubMed ID: 8814476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute theophylline toxicity and the use of esmolol to reverse cardiovascular instability.
    Seneff M; Scott J; Friedman B; Smith M
    Ann Emerg Med; 1990 Jun; 19(6):671-3. PubMed ID: 1971502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of esmolol on the hemodynamics of acute theophylline toxicity.
    Gaar GG; Banner W; Laddu AR
    Ann Emerg Med; 1987 Dec; 16(12):1334-9. PubMed ID: 3688594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol.
    Felix SB; Stangl V; Kieback A; Doerffel W; Staudt A; Wernecke KD; Baumann G; Stangl K
    J Cardiovasc Pharmacol; 2001 Nov; 38(5):666-71. PubMed ID: 11602813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonthrombolytic intervention in acute myocardial infarction.
    Kirshenbaum JM
    Am J Cardiol; 1989 Jul; 64(4):25B-28B. PubMed ID: 2568748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two esmolol bolus doses on the haemodynamic response and seizure duration during electroconvulsive therapy.
    Kovac AL; Goto H; Pardo MP; Arakawa K
    Can J Anaesth; 1991 Mar; 38(2):204-9. PubMed ID: 1673645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terbutaline sulfate overdose.
    Lee DC
    Ann Emerg Med; 1995 Jul; 26(1):107-8. PubMed ID: 7793711
    [No Abstract]   [Full Text] [Related]  

  • 8. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings.
    Turlapaty P; Laddu A; Murthy VS; Singh B; Lee R
    Am Heart J; 1987 Oct; 114(4 Pt 1):866-85. PubMed ID: 2889341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
    Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
    Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
    Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
    Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esmolol: a short-acting titratable beta-blocker in acute myocardial ischemia.
    Viray R; Turlapaty P; Laddu A
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):153-61. PubMed ID: 2900818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
    Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR
    J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effective treatment of theophylline poisoning using a beta adrenergic blockader].
    Katona Z
    Orv Hetil; 1990 Jul; 131(29):1591-2. PubMed ID: 1975436
    [No Abstract]   [Full Text] [Related]  

  • 14. Esmolol in acute ischemic syndromes.
    Mitchell RG; Stoddard MF; Ben-Yehuda O; Aggarwal KB; Allenby KS; Trillo RA; Loyd R; Chang CT; Labovitz AJ
    Am Heart J; 2002 Nov; 144(5):E9. PubMed ID: 12422138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Esmolol in anesthesiology: pharmacology and indications].
    Fita G; Gomar C; Rovira I
    Rev Esp Anestesiol Reanim; 1999 Nov; 46(9):404-14. PubMed ID: 10613078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esmolol in a case of severe tetanus. Adequate haemodynamic control achieved despite markedly elevated catecholamine levels.
    Beards SC; Lipman J; Bothma PA; Joynt GM
    S Afr J Surg; 1994 Mar; 32(1):33-5. PubMed ID: 11218441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of esmolol in a parturient with hypertrophic obstructive cardiomyopathy.
    Fairley CJ; Clarke JT
    Br J Anaesth; 1995 Dec; 75(6):801-4. PubMed ID: 8672338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
    Kirshenbaum JM; Kloner RF; McGowan N; Antman EM
    J Am Coll Cardiol; 1988 Sep; 12(3):773-80. PubMed ID: 2900259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of esmolol in unstable angina pectoris. European Esmolol Study Group.
    Hohnloser SH; Meinertz T; Klingenheben T; Sydow B; Just H
    Am J Cardiol; 1991 Jun; 67(16):1319-23. PubMed ID: 1675036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esmolol in the treatment of severe arrhythmia after acute trichloroethylene poisoning.
    Mortiz F; de La Chapelle A; Bauer F; Leroy JP; Goullé JP; Bonmarchand G
    Intensive Care Med; 2000 Feb; 26(2):256. PubMed ID: 10784325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.